What the six lenses say about THYROCARE — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.
How THYROCARE’s own sector index is moving — context for reading the stock’s six lenses.
Six-lens read
The actual numbers
The actual numbers
Full 8-quarter history in the financials table below.
The actual numbers
The actual numbers
Every filing in the corporate-announcements panel below.
The actual numbers
Decile — each lens’s 0–100 score is ranked against every Micro-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.
Conviction — the average of the two active conviction-lens deciles (Technical & Flow):
Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.
Glass box
Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.
Policy
Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.
PLI Scheme — Pharmaceuticals & API
Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices
Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-09-08.
| Baseline | 1D | 1W | 1M | 3M | 6M | 12M |
|---|---|---|---|---|---|---|
Nifty 50 Large-cap anchor | -0.0pp | -3.9pp | -0.7pp | +3.0pp | +57.7pp | +34.1pp |
Nifty 500 Broad-market baseline | -0.1pp | -3.9pp | -1.7pp | +1.4pp | +52.0pp | +28.9pp |
Sector Own-sector index | — | — | -4.6pp | -4.6pp | +38.8pp | +8.1pp |
From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).
Trend
THYROCARE daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.
Relative strength
THYROCARE ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.
TradingView composite technical analysis — multi-timeframe consensus
Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.
| Metric | Jun '24 | Sep '24 | Dec '24 | Mar '25 | Jun '25 | Sep '25 | Dec '25 | Mar '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue (₹cr) | 157 | 177 | 166 | 187 | 193 | 217 | 196 | 224 |
| ↳ change QoQ | — | +13.0% | -6.4% | +12.7% | +3.2% | +12.4% | -9.7% | +14.3% |
| EBITDA (₹cr) | 46 | 51 | 46 | 57 | 58 | 71 | 58 | 75 |
| EBITDA margin | 29.5% | 28.7% | 27.6% | 30.5% | 30.0% | 32.7% | 29.6% | 33.5% |
| PAT (₹cr) | 24 | 47 | 19 | 22 | 38 | 48 | 28 | 49 |
| ↳ change QoQ | — | +96.9% | -59.8% | +16.1% | +72.7% | +26.3% | -41.7% | +75.0% |
| Net margin | 15.3% | 26.6% | 11.4% | 11.8% | 19.7% | 22.1% | 14.3% | 21.9% |
| EPS (₹) | 4.52 | 4.99 | 3.58 | 1.36 | 2.45 | 3.02 | 1.82 | 2.96 |
| D/E | — | — | — | — | — | — | — | — |
Filings to the exchange — capital actions, earnings and governance. Most recent first.
A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗…and 5 more.
Ownership
Mutual funds holding THYROCARE (10)
| Fund | Weight | AUM ₹cr | Grade |
|---|---|---|---|
| HSBC Midcap Gr | 1.63% | 15,578 | |
| Aditya BSL ELSS Tax Saver Gr LSP | 1.32% | 14,660 | |
| Aditya BSL ELSS Tax Saver Gr | 1.32% | 14,660 | |
| Nippon India Pharma Bns | 2.51% | 9,279 | |
| Nippon India Pharma Gr | 2.51% | 9,279 | |
| ICICI Pru Pharma Healthcare Diag Gr | 1.95% | 6,803 | |
| HSBC Large & Mid Cap Reg Gr | 1.84% | 5,479 | |
| HDFC Pharma and Healthcare Reg Gr | 1.42% | 2,940 | |
| Bank of India Small Cap Reg Gr | 0.82% | 2,819 | |
| Aditya BSL Pharma & Hlthcare Reg Gr | 1.91% | 1,074 |
ETFs holding THYROCARE (0)
No tracked ETF holds THYROCARE ≥0.5%.